Roger Jeffs - Mar 31, 2022 Form 4 Insider Report for Liquidia Corp (LQDA)

Role
Chief Executive Officer, Director
Signature
/s/ Roger Jeffs
Stock symbol
LQDA
Transactions as of
Mar 31, 2022
Transactions value $
$0
Form type
4
Date filed
4/20/2022, 04:35 PM
Previous filing
Mar 8, 2022
Next filing
Oct 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LQDA Common Stock Award $0 +154K +11.11% $0.00 1.54M Mar 31, 2022 See footnote F1, F2
holding LQDA Common Stock 112K Mar 31, 2022 Direct
holding LQDA Common Stock 6.1K Mar 31, 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 31, 2022, 154,167 shares of the Issuer's common stock which were previously subject to a holdback pursuant to the terms of the merger agreement for Issuer's acquisition of RareGen, LLC ("RareGen") were released to the Reporting Person. The merger agreement provided that certain shares of the Issuer's common stock issuable to members of RareGen at the closing of the transaction would be held back as partial security for the benefit of the Issuer with respect to any indemnifiable damages pursuant to the indemnification obligations of the members of RareGen. The shares would subsequently be released for no additional consideration, subject to the cancellation of shares of the Issuer's common stock in connection with any such indemnifiable damages.
F2 The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.
F3 The securities are held by Roger A. Jeffs 2019 GRAT dtd 05/01/2019 (the "Trust"). The Reporting Person is the trustee of the Trust.